Business Context and Reporting Period
Company: Atomera Inc (ATOM)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2026
Business Overview: Atomera is an early-stage semiconductor technology company developing and licensing proprietary processes (MST) to enhance transistor performance. The company operates as a single segment, focusing on R&D and commercialization rather than manufacturing wafers directly.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended June 30, 2026 |
6 Months Ended June 30, 2026 |
6 Months Ended June 30, 2025 |
|---|---|---|---|
| Revenue | $158 | $169 | $4 |
| Cost of Revenue | $(26) | $(152) | $(62) |
| Gross Profit | $132 | $17 | $(58) |
| Operating Expenses | $(6,891) | $(13,100) | $(10,660) |
| Loss from Operations | $(6,759) | $(13,083) | $(10,718) |
| Net Loss | $(6,336) | $(12,409) | $(10,176) |
| Net Loss Per Share (Basic/Diluted) | $(0.17) | $(0.34) | $(0.34) |
Liquidity and Balance Sheet Highlights (in thousands)
- Cash and Cash Equivalents: $15,146 (June 30, 2026) vs. $19,210 (Dec 31, 2025)
- Short-term Investments: $23,206 (June 30, 2026) vs. $0 (Dec 31, 2025)
- Total Current Assets: $38,952
- Total Current Liabilities: $2,288
- Working Capital: Approximately $36.7 million
- Total Liabilities: $3,148 (Primarily operating and financing lease liabilities)
- Stockholders' Equity: $37,075
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased significantly to $158,000 for the quarter and $169,000 for the six months ended June 30, 2026, compared to $0 and $4,000 in the prior year periods. This was driven by engineering services revenue from MST wafer delivery.
- Operating Expenses: Total operating expenses rose to $6.9 million (Q2) and $13.1 million (YTD) from $5.2 million and $10.7 million in the prior year.
- R&D: Increased due to higher bonus accruals, stock-based compensation, and tool lease costs.
- G&A: Increased 55% QoQ and 33% YoY, driven by bonus accruals, stock-based compensation, and legal/patent filing fees.
- Selling & Marketing: Increased 210% QoQ and 223% YoY due to headcount expansion and recruiting fees.
- Capital Raising: The company completed a registered direct offering in February 2026, raising approximately $23.6 million net. Additionally, $3.1 million was raised via At-The-Market (ATM) sales during the six-month period.
- Investment Activity: The company deployed significant cash into short-term investments ($23.2 million balance), resulting in a net cash outflow of $23.1 million from investing activities for the six months ended June 30, 2026.
Outlook, Risks, and Management Commentary
- Liquidity Outlook: Management believes current capital resources ($38.4 million in cash and short-term investments) are sufficient to fund operations for at least the next 12 months. Future funding needs depend on commercialization success.
- Commercialization Strategy: The company continues to pursue commercial license agreements (R&D and High-Volume Manufacturing) and royalties. MSTcad software licensing and engineering services serve as precursors to these larger deals.
- Technology Expansion: Atomera is applying MST technology to compound semiconductors (e.g., Gallium Nitride) to address lattice mismatch issues, expanding beyond traditional silicon CMOS applications.
- Risks:
- Recurring operating losses and dependence on future capital raises.
- Uncertainty in commercializing technology and securing high-volume manufacturing licenses.
- Competition and technological developments in the semiconductor industry.
- Unusual Items: Significant accretion income ($235,000 YTD) was recognized from available-for-sale securities. Stock-based compensation expense was $3.1 million for the six months ended June 30, 2026.
Investor Verification Checklist
- Runway Validation: Verify the 12-month liquidity runway claim against current burn rates and potential delays in licensing revenue.
- Revenue Quality: Assess the sustainability of the $158k quarterly revenue, distinguishing between one-time engineering services and recurring license/royalty income.
- Expense Trajectory: Monitor the rapid increase in Selling & Marketing and G&A expenses to ensure they correlate with tangible progress in customer acquisition.
- Capital Structure: Review the impact of the recent registered direct offering and ATM sales on shareholder dilution (shares outstanding increased from ~32.4M to ~39.0M).
- Lease Obligations: Confirm future cash requirements related to the epitaxial deposition tool leases and the extended corporate headquarters lease.